POLA-R-CHP: POLATUZUMAB VEDOTIN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA

Subjects

Subjects :

Cancer Research
business.industry
Cyclophosphamide/doxorubicin/prednisone
Hematology
General Medicine
medicine.disease
Polatuzumab vedotin
03 medical and health sciences
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
medicine
Cancer research
Rituximab
business
Diffuse large B-cell lymphoma
030215 immunology
medicine.drug

Details

ISSN :

02780232

Volume :

35

Database :

OpenAIRE

Journal :

Hematological Oncology

Accession number :

edsair.doi...........c5dd2abd74e6370f1aabf605b468c34e

Full Text :

https://doi.org/10.1002/hon.2437_79